Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center.Alicia McGhie, Jenessa Lee, Alessandra Ferrajoli, Adam J DiPippo
No abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app